A positive feedback loop of heparanase/ syndecan1/nerve growth factor regulates cancer pain progression

키워드

참고문헌 (40)

1. Neufeld NJ, "Cancer pain : a review of epidemiology, clinical quality and value impact", Future Oncol, 13, pp.833~841 (2017)
2. Lovell M, "Australian survey of current practice and guideline use in adult cancer pain assessment and management : perspectives of palliative care physicians", J Palliat Med, 16, pp.1403~1409 (2013)
3. Magee D, "Cancer pain: where are we now?", Pain Manag, 9, pp.63~79 (2019)
4. Sanderson RD, "Heparanase regulation of cancer, autophagy and inflammation : new mechanisms and targets for therapy", FEBS J, 284, pp.42~55 (2017)
5. Rivara S, "Heparanase : a rainbow pharmacological target associated to multiple pathologies including rare diseases", Future Med Chem, 8, pp.647~680 (2016)
6. Doweck I, "Opposing effects of heparanase and heparanase-2 in head & neck cancer", Adv Exp Med Biol, 1221, pp.847~856 (2020)
7. Hermano E, "Heparanase accelerates obesity-associated breast cancer progression", Cancer Res, 79, pp.5342~5354 (2019)
8. Heyman B, "Mechanisms of heparanase inhibitors in cancer therapy", Exp Hematol, 44, pp.1002~1012 (2016)
9. Jiang X, "Inhibition of triple-negative breast cancer tumor growth by electroacupuncture with encircled needling and its mechanisms in a mice xenograft model", Int J Med Sci, 16, pp.1642~1651 (2019)
10. Demir IE, "Nerve growth factor & TrkA as novel therapeutic targets in cancer", Biochim Biophys Acta, 1866, pp.37~50 (2016)
11. Wang W, "The role of nerve growth factor and its receptors in tumorigenesis and cancer pain", Biosci Trends, 8, pp.68~74 (2014)
12. Di Donato M, "Nerve growth factor induces proliferation and aggressiveness in prostate cancer cells", Cancers(Basel), 11, pp.784~ (2019)
13. Hayakawa Y, "Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling", Cancer Cell, 31, pp.21~34 (2017)
14. Han L, "Sonic hedgehog signaling pathway promotes pancreatic cancer pain via nerve growth factor", Reg Anesth Pain Med, 45, pp.137~144 (2020)
15. Teixeira FCOB, "Involvement of Syndecan-1and heparanase in cancer and inflammation", Adv Exp Med Biol, 1221, pp.97~135 (2020)
16. Jayatilleke KM, "Heparanase and the hallmarks of cancer", J Transl Med, 18, pp.453~ (2020)
17. Sayyad MR, "Syndecan-1 facilitates breast cancer metastasis to the brain", Breast Cancer Res Treat, 178, pp.35~49 (2019)
18. Chute C, "Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases", Breast Cancer Res, 20, pp.66~ (2018)
19. Calixto-Campos C, "Quercetin reduces Ehrlich tumor-induced cancer pain in mice", Anal Cell Pathol (Amst), 2015, pp.285708~ (2015)
20. Pellati F, "Cannabis sativa L. and nonpsychoactive cannabinoids : their chemistry and role against oxidative stress, inflammation, and cancer", Biomed Res Int, 2018, pp.1691428~ (2018)
21. Masola V, "Role of heparanase in tumor progression : molecular aspects and therapeutic options", Semin Cancer Biol, 62, pp.86~98 (2020)
22. Hermano E, "Macrophage polarization in pancreatic carcinoma : role of heparanase enzyme", J Natl Cancer Inst, 106 (2014)
23. Vlodavsky I, "Heparanase : from basic research to therapeutic applications in cancer and inflammation", Drug Resist Updat, 29, pp.54~75 (2016)
24. Ramani VC, "Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma", Oncotarget, 7, pp.1598~1607 (2016)
25. Hao NB, "Hepatocyte growth factor(HGF)upregulates heparanase expression via the PI3K", Akt, Cancer Lett, pp.2015, 361[DOI]
26. Luan Q, "Mutual enhancement between heparanase and vascular endothelial growth factor : a novel mechanism for melanoma progression", Cancer Lett, 308, pp.100~111 (2011)
27. Wei RR, "CTC clusters induced by heparanase enhance breast cancer metastasis", Acta Pharmacol Sin, 39, pp.1326~1337 (2018)
28. Barash U, "Involvement of heparanase in the pathogenesis of mesothelioma : basic aspects and clinical applications", J Natl Cancer Inst, 110, pp.1102~1114 (2018)
29. Ramani VC, "Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype", Matrix Biol, 55, pp.22~34 (2016)
30. Renz BW, "β2 adrenergic-neurotrophin feedforward loop promotes pancreatic cancer", Cancer Cell, 33, pp.75~90 (2018)
31. Salvo E, "TNFα promotes oral cancer growth, pain, and Schwann cell activation", Sci Rep, 11, pp.1840~ (2021)
32. Lin H, "Nerve growth factor regulates liver cancer cell polarity and motility", Mol Med Rep, 23, pp.288~ (2021)
33. Garrido MP, "NGF", TRKA decrease miR-145-5p levels in epithelial ovarian cancer cells, 2020, pp.21, 7657~
34. Faulkner S, "Nerve growth factor and its receptor tyrosine kinase TrkA are overexpressed in cervical squamous cell carcinoma", FASEB Bioadv, 2, pp.398~408 (2020)
35. Parimon T, "Syndecan-1 controls lung tumorigenesis by regulating miRNAs packaged in exosomes", Am J Pathol, 188, pp.1094~1103 (2018)
36. Binder Gallimidi A, "Syndecan-1deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma", PLoS One, 12, pp.e0174343~ (2017)
37. Zhang Y, "Cell surface-anchored syndecan-1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis", J Cell Mol Med, 21, pp.13~25 (2017)
38. Ibrahim SA, "Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6", STAT3, Notch and EGFR signaling pathways, 2017, pp.16, 57~
39. Yang Y, "MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1", Int J Oncol, 53, pp.1204~1214 (2018)
40. Yu S, "Heparanase-1-induced shedding of heparan sulfate from syndecan-1 in hepatocarcinoma cell facilitates lymphatic endothelial cell proliferation via VEGF-C", ERK pathway, 2017, pp.485, 432~439

관련 논문AI추천